Clinical trials: Precision Screening
Danon Disease, Fabry Disease
Precision Diagnosis and Risk Stratification of Rare Cardiomyopathies Based on Novel Cardiac Magnetic Resonance Techniques
What is this study about? This research is focused on improving the care for people with rare heart muscle diseases, known as rare cardiomyopathies.
- Conditions
- Danon Disease, Fabry Disease, Cardiac Amyloidosis, Noonan Syndrome
- Trial name
- NCT07336394
- Where
- China
- Volunteers
- 1,000 people, healthy volunteers welcome
- Sponsor
- Chinese Academy of Medical Sciences, Fuwai Hospital
Adolescent Idiopathic Scoliosis (AIS)
Construction of a Screening and Precision Intervention System for Adolescent Idiopathic Scoliosis Based on the DIERS Spinal Moiré System
Taking the DIERS Spinal Moiré System as the primary tool, this study intends to establish an early warning model for adolescent scoliosis based on the system, verify the quantitative relationship between different body postures…
- Trial name
- NCT07899294
- Where
- China
- Volunteers
- 500 people
- Sponsor
- Jiawei Jiang
Haematological Malignancy, Solid Tumour
DETERMINE (Determining Extended Therapeutic Indications for Existing Drugs in Rare Molecularly Defined Indications Using a National Evaluation Platform Trial) - Master Screening Protocol
DETERMINE is an open-label phase II/III trial. It will look at targeted treatments in rare cancers or common cancers with rare genetic change (mutation). Patients must have a cancer with an identified mutation.
- Trial name
- DETERMINE (NCT05722886)
- Testing
- Alectinib, Atezolizumab, Entrectinib
- Where
- 27 sites in United Kingdom
- Volunteers
- 825 people
- Sponsor
- Cancer Research UK
Colorectal Cancer Screening, Prevention & Control
Outreach for Patients With Uncompleted Colorectal Cancer Screening Orders
The purpose of this study is to evaluate whether patient outreach is effective at increasing compliance with preventive screenings ordered by their physician. We hypothesize that educational outreach may increase completion rates.
- Trial name
- UPQUAL (NCT00793455)
- Testing
- Educational outreach
- Where
- United States
- Volunteers
- 628 people
- Sponsor
- Northwestern University
Monogenic Diabetes
Screening and Molecular Diagnosis-based Individualized Precision Management of Monogenic Diabetes
The goal of this observational study is to establish a registry, screening, and individualized management platform for patients with monogenic diabetes mellitus(MDM) using internet-based and mobile application software.
- Trial name
- NCT06746610
- Testing
- Genetic Screening for Monogenic Diabetes
- Where
- China
- Volunteers
- 2,000 people
- Sponsor
- Tianjin Medical University General Hospital